Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit

INTRODUCTION: Many patients with mucinous appendiceal adenocarcinoma experience peritoneal recurrence despite complete cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Prior work has demonstrated that repeat CRS/HIPEC can prolong survival in select patients. We soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhutiani, Neal, Grotz, Travis E., Concors, Seth J., White, Michael G., Helmink, Beth A., Raghav, Kanwal P., Taggart, Melissa W., Beaty, Karen A., Royal, Richard E., Overman, Michael J., Matamoros, Aurelio, Scally, Christopher P., Rafeeq, Safia, Mansfield, Paul F., Fournier, Keith F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695875/
https://www.ncbi.nlm.nih.gov/pubmed/37872456
http://dx.doi.org/10.1245/s10434-023-14422-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695875/
https://www.ncbi.nlm.nih.gov/pubmed/37872456
http://dx.doi.org/10.1245/s10434-023-14422-2

Ejemplares similares